A

Arcellx

94 employees

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
oncology
Life Science
biotechnology
Biopharma
Health Care
cell therapy
multiple myeloma
car-t

Date founded

2015

Funding rounds raised

Total raised

$115M

from 16 investors over 16 rounds

A

Arcellx raised $100M on December 9, 2022

Investors: -

A

Arcellx raised $115M on April 13, 2021

Investors: Suvretta Capital Management LLC, Samsara BioCapital, Soleus Capital Management, L.P., Takeda UK Limited, Novo Holdings, Surveyor Capital, S.R. One Ltd and Sixty Degree Capital

A

Arcellx raised $85M on October 3, 2019

Investors: JVC Investment Partners, LG Technology Ventures, Quan Capital 泉创资本, Solasta Ventures, Novo Holdings, Takeda UK Limited and S.R. One Ltd

FAQ